Dr. Vikas Agarwal, MD

Dr. Agarwal practices at Mosaic Life Care at St. Joseph - Medical Center in Saint Joseph, Missouri, part of Mosaic Life Care.

Dr. Agarwal's NPI, 1306939244, was assigned on October 2, 2006. Dr. Agarwal holds Missouri license 2001009329.

Dr. Agarwal's primary practice is Mosaic Life Care at St. Joseph - Medical Center, at 5325 Faraon Street, Saint Joseph, MO 64506 in Buchanan County. The practice phone is (816) 271-6000.

Dr. Agarwal's primary practice is Mosaic Life Care at St. Joseph - Medical Center in Saint Joseph, Missouri, part of Mosaic Life Care. Dr. Agarwal is also affiliated with Mosaic Medical Center - Maryville. The medical group on file is Mosaic Life Care at St. Joseph - Medical Center. Dmand AI also links Dr. Agarwal to 2 more home health agencies, 2 hospices and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Agarwal is licensed in Missouri.

CMS data shows 4,250 Medicare services from Dr. Agarwal across 15 procedure codes in 2024, for 629 Medicare patients. Medicare paid $230,005 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 629 Medicare patients who saw Dr. Agarwal in 2024. The largest group is 65 to 74, with 251 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 74, with 52% women.

In 2024, Dr. Agarwal wrote 11,531 Medicare Part D claims for 837 patients. 92% of them were for generic drugs. CMS names the drug for 10,907 of them, across 122 drugs with 11 or more claims each, at $653,161 in total drug cost. In 2023, CMS named 10,201 claims across 116 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Agarwal for performance year 2024, reported as part of a group. Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of removal of skin lesions by Dr. Agarwal, more than 64% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 400 papers to Dr. Agarwal, published from 2004 to 2025. 2021 was the busiest year, with 44. The most frequent topics are COVID-19, India and Myositis. Dr. Agarwal has published most often in Rheumatol Int. Dr. Agarwal's most frequent co-authors are Rohit Aggarwal, MD, Tulika Chatterjee, MD and John R. Laird, MD.

Dmand AI links Dr. Agarwal to 1 clinical trial. Conditions studied include Critical Illness and Acute Kidney Injury.

CMS Open Payments shows 3 general payments to Dr. Agarwal from 2 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $119.